移植后高脂血症
Post-transplant hyperlipidaemia.
作者信息
Jindal R M
机构信息
Department of Surgery, Indiana University School of Medicine, Indianapolis 46202, USA.
出版信息
Postgrad Med J. 1997 Dec;73(866):785-93. doi: 10.1136/pgmj.73.866.785.
Abstract
The correction of post-transplant hyperlipidaemia warrants the judicious and timely use of pharmacological agents with dietary modification and exercise. Reduction in hyperlipidaemia may have some role in decreasing the incidence of chronic rejection of allografts. The awareness that the morbidity and mortality of atherosclerotic disease may be lowered by active intervention will result in a better quality of life for transplant recipients.
摘要
移植后高脂血症的纠正需要合理且及时地使用药物，并配合饮食调整和运动。降低高脂血症可能在降低同种异体移植物慢性排斥反应的发生率方面发挥一定作用。认识到通过积极干预可以降低动脉粥样硬化疾病的发病率和死亡率，将有助于提高移植受者的生活质量。
相似文献
1
Post-transplant hyperlipidaemia.移植后高脂血症
Postgrad Med J. 1997 Dec;73(866):785-93. doi: 10.1136/pgmj.73.866.785.
2
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.他克莫司在胰腺移植中的应用：一项多中心分析。他克莫司胰腺移植研究组。
Clin Transplant. 1997 Aug;11(4):299-312.
3
Tacrolimus in transplant rejection.他克莫司在移植排斥中的应用。
Expert Opin Pharmacother. 2013 Jan;14(1):115-22. doi: 10.1517/14656566.2013.751374. Epub 2012 Dec 10.
4
Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.儿童实体器官移植受者中钙调神经磷酸酶抑制剂诱导的肾毒性的治疗策略。
Pediatr Transplant. 2006 Sep;10(6):721-9. doi: 10.1111/j.1399-3046.2006.00577.x.
5
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.他克莫司与环孢素作为肺移植受者的初始免疫抑制治疗比较
Cochrane Database Syst Rev. 2013 May 31(5):CD008817. doi: 10.1002/14651858.CD008817.pub2.
6
Hyperlipidaemia in immunosuppression.免疫抑制状态下的高脂血症
Curr Opin Lipidol. 2016 Dec;27(6):631-632. doi: 10.1097/MOL.0000000000000363.
7
Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both?肝移植受者的心脏肥大：他克莫司、环孢素还是两者皆有？
Transplantation. 2003 Jul 27;76(2):446-7; author reply 447-8. doi: 10.1097/01.TP.0000077419.91788.30.
8
The metabolic effects of cyclosporin and tacrolimus.
J Endocrinol Invest. 2000 Jul-Aug;23(7):482-90. doi: 10.1007/BF03343761.
9
Calcineurin inhibitors in renal transplantation: what is the best option?肾移植中的钙调神经磷酸酶抑制剂：最佳选择是什么？
Drugs. 2003;63(15):1535-48. doi: 10.2165/00003495-200363150-00002.
10
Refractory Dyslipidemia After Liver Transplant: Case Study With Successive Histologic Investigations.肝移植后难治性血脂异常：连续组织学调查的病例研究
Exp Clin Transplant. 2015 Aug;13(4):371-5. doi: 10.6002/ect.2014.0051. Epub 2015 Apr 28.
引用本文的文献
1
Transplant endocrinology.移植内分泌学
Med J Armed Forces India. 2023 Nov-Dec;79(6):651-656. doi: 10.1016/j.mjafi.2023.08.017. Epub 2023 Sep 12.
2
Calcineurin inhibitors and post-transplant hyperlipidaemias.钙调神经磷酸酶抑制剂与移植后高脂血症
Drug Saf. 2001;24(10):755-66. doi: 10.2165/00002018-200124100-00004.
本文引用的文献
1
Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: pathogenesis, diagnosis, and management.原位肝移植后的高脂血症及其他冠状动脉危险因素：发病机制、诊断与管理。
Liver Transpl Surg. 1995 Sep;1(5 Suppl 1):29-38.
2
3
Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.霉酚酸酯用于肾移植受者：三项预防排斥反应的随机、双盲临床研究的汇总疗效分析。国际霉酚酸酯肾移植研究组
Transplantation. 1997 Jan 15;63(1):39-47. doi: 10.1097/00007890-199701150-00008.
4
Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.肝移植术后高脂血症：自然病程及羟甲基戊二酰辅酶A还原酶抑制剂普伐他汀的治疗
Transplantation. 1996 Oct 15;62(7):934-42. doi: 10.1097/00007890-199610150-00011.
5
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.普伐他汀对胆固醇水平正常的心肌梗死患者冠状动脉事件的影响。胆固醇与再发事件试验研究人员。
N Engl J Med. 1996 Oct 3;335(14):1001-9. doi: 10.1056/NEJM199610033351401.
6
The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients.
Kidney Int. 1996 Jan;49(1):209-16. doi: 10.1038/ki.1996.28.
7
Metabolic problems in recipients of liver transplants.肝移植受者的代谢问题。
Clin Transplant. 1996 Apr;10(2):213-7.
8
Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention.糖尿病的心血管并发症：我们所知道的以及我们需要了解的关于其预防的知识。
Ann Intern Med. 1996 Jan 1;124(1 Pt 2):123-6. doi: 10.7326/0003-4819-124-1_part_2-199601011-00008.
9
Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents?非胰岛素依赖型糖尿病和心血管疾病有共同的发病因素吗？
Ann Intern Med. 1996 Jan 1;124(1 Pt 2):110-6. doi: 10.7326/0003-4819-124-1_part_2-199601011-00006.
10
Approaches to the treatment of hyperlipidemia in the solid organ transplant recipient.
Ann Pharmacother. 1995 Sep;29(9):879-91. doi: 10.1177/106002809502900911.
Zotero 插件